With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Here's every single that topped the charts this year, based on new formula that tallies physical sales, airplay, and streams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results